SCHEMBL17336252

SCHEMBL17336252

O=CCc1ccc(Br)c(CBr)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15822081 0.84 SNCA (0.32) —
SCHEMBL17336260 0.82 — —
SCHEMBL17336263 0.82 EGFR (0.34) —
SCHEMBL27672757 0.81 TSHR (0.36) —
SCHEMBL28879804 0.79 PTPRC (0.36) —
SCHEMBL23647876 0.75 CA2 (0.33) —
SCHEMBL29790996 0.75 CA2 (0.33) —
SCHEMBL28409734 0.75 SNCA (0.33) —
SCHEMBL2936648 0.75 TRPA1 (0.40) —
SCHEMBL15516408 0.74 L3MBTL1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154984-A1 PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2017-04-19 — — EP disclosed
WO-2015191437-A1 PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS GILEAD PHARMASSET LLC (US) 2015-12-17 — — WO disclosed
Send feedback